DreamCIS, Inc. (KOSDAQ:223250)
South Korea · Delayed Price · Currency is KRW 3,815.00
-20.00 (-0.52%)
At close: Nov 13, 2026
DreamCIS Market Cap
DreamCIS has a market cap or net worth of 93.85 billion as of November 13, 2026. It is the 27,448th most valuable company in the world and the 1,271st biggest in South Korea. Its market cap has decreased by 8.61% in one year.
Market Cap
93.85B
Enterprise Value
83.22B
Revenue
73.28B
Global Rank
Country Rank
#1,271 South Korea
PE Ratio
312.09
ChartMarket Cap Chart
Since May 22, 2020, DreamCIS's market cap has decreased from 165.28B to 93.85B, a decrease of -43.22%. That is a compound annual growth rate of -8.36%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 93.85B | -38.19% |
| Dec 30, 2025 | 151.84B | 116.27% |
| Dec 30, 2024 | 70.21B | -9.03% |
| Dec 28, 2023 | 77.17B | 25.17% |
| Dec 29, 2022 | 61.65B | -15.87% |
| Dec 30, 2021 | 73.28B | -32.30% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| May 22, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ingenia Therapeutics | 1.02T |
| Penetrium Bioscience | 334.06B |
| HLB bioStep | 75.19B |
| P&K Skin Research Center | 52.56B |
| Kolmar BioTech | 30.76B |
| SLS BIO | 26.89B |
| DT&CRO CO. | 26.14B |
| C&R Research | 22.94B |